4.7 Article

New Generation of Inactivated Poliovirus Vaccines for Universal Immunization after Eradication of Poliomyelitis

Journal

CLINICAL INFECTIOUS DISEASES
Volume 47, Issue 12, Pages 1587-1592

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1086/593310

Keywords

-

Funding

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health
  2. US Food and Drug Administration
  3. US Department of Health and Human Services

Ask authors/readers for more resources

Twenty years of global polio eradication efforts may soon eliminate the transmission of wild-type poliovirus. However, new information that has been learned about poliovirus, as well as the political realities of a modern world, demand that universal immunity against poliomyelitis be maintained, even after wild-type poliovirus is eradicated. Although 2 excellent vaccines have proven to be highly effective in the past, neither the live-attenuated vaccine nor the currently used inactivated vaccine are optimal for use in the posteradication era. Therefore, concerted efforts are urgently needed to develop a new generation of vaccine that is risk-free and affordable and can be produced on a global scale. Here, we discuss the desired properties of a vaccine and methods to create a new polio vaccine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available